REAL-WORLD OUTCOMES WITH MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA ACCORDING TO SMOKING HISTORY AND COPD STATUS AT ENROLLMENT: REALITI-A POST HOC ANALYSIS

被引：0
|
作者：
Bagnasco, Diego
Hill, David G.
Welte, Tobias
Chaudhuri, Rekha
Price, Robert
Howarth, Peter
机构：
来源：
CHEST | 2023年 / 164卷 / 04期
关键词：
D O I：
10.1016/j.chest.2023.07.102
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：75A / 76A
页数：2
相关论文
共 50 条
  • [41] Real-world clinical outcomes for patients in the UK with severe, atopic eosinophilic asthma treated with benralizumab
    Jackson, D. J.
    Dube, S.
    Morris, T.
    Burhan, H.
    Pfeffer, P.
    ALLERGY, 2020, 75 : 40 - 40
  • [42] Clinical remission in patients with severe eosinophilic asthma with benralizumab according to body mass index status in an integrated analysis of the real-world XALOC-1 study
    Jackson, D.
    Pelaia, G.
    Padilla-Galo, A.
    Tran, T. N.
    Shih, V.
    Cohen, D.
    Watt, M.
    Kayaniyil, S.
    Boarino, S.
    Nuevo, J.
    Kwiatek, J.
    Shavit, A.
    Emmanuel, B.
    Nair, P.
    ALLERGY, 2023, 78
  • [43] Long-Term Real-World Outcomes of Mepolizumab and Benralizumab Among Biologic-Naive Patients With Severe Eosinophilic Asthma: Experience of 3 Years' Therapy
    Fyles, Fred
    Nuttall, Amy
    Joplin, Hannah
    Burhan, Hassan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (09): : 2715 - 2723
  • [44] Late Breaking Abstract- Mepolizumab treatment in children and adolescents with severe eosinophilic asthma (CASAM)-A real-world study:initial analysis
    Gupta, Latika
    Messa, Ines De Mir
    Valverde-Molina, Jose
    Murray, Clare
    Izquierdo, Ana Diez
    Canavate, Ana Martinez
    Pike, Katharine
    Gracia, Carolina Diaz
    Callejon, Alicia Callejon
    Nagakumar, Prasad
    Blazquez, Olga De La Serna
    Cook, James
    Valdesoiro, Laura
    Moron, Juan Navarro
    Gaboli, Mirella
    Corullon, Silvia Castillo
    De Atauri, Alvaro Gimeno Diaz
    Aguilera, Pilar Caro
    Blasco, Jaime Lozano
    Aliaga, Yolanda
    Neyra, Alejandro Lopez
    Turnbull, Andrew
    Elosegui, Paula Corcuera
    Nwokoro, Chinedu
    Gupta, Atul
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [45] Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab:a post-hoc analysis of the 2-year RELIght study
    Papaioannou, Andriana
    Kallieri, Maria
    Zervas, Eleftherios
    Fouka, Evangelia
    Porpodis, Konstaninos
    Hadjimitrova, Marija
    Tzortzaki, Eleni
    Makris, Michael
    Ntakoula, Maria
    Lyberopoulos, Panagiotis
    Dimakou, Katerina
    Koukidou, Sofia
    Ampelioti, Sevasti
    Papaporfyriou, Anastasia
    Katsoulis, Konstantinos
    Kipourou, Maria
    Rovina, Nikoletta
    Antoniou, Katerina
    Vittorakis, Stylianos
    Bakakos, Petros
    Steiropoulos, Paschalis
    Markopoulou, Katerina
    Avarlis, Panteleimon
    Papanikolaou, lias
    Markatos, Miltiadis
    Gaki, Eleni
    Samitas, Konstantinos
    Glynos, Konstantinos
    Papiris, Spyros
    Papakosta, Despoina
    Tzanakis, Nikolaos
    Gaga, Mina
    Kostikas, Konstantinos
    Loukides, Stelios
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [46] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: ORBE II study
    Alicia Padilla-Galo
    Isabel Moya Carmona
    Pilar Ausín
    Luis Carazo Fernández
    Ismael García-Moguel
    José Luis Velasco-Garrido
    Rubén Andújar-Espinosa
    Francisco Casas-Maldonado
    Eva Martínez-Moragón
    Carlos Martínez Rivera
    Elisabet Vera Solsona
    Fernando Sánchez-Toril López
    Andrea Trisán Alonso
    Marina Blanco Aparicio
    Marcela Valverde-Monge
    Borja Valencia Azcona
    Marta Palop Cervera
    Javier Nuevo
    Jesús Sánchez Tena
    Gustavo Resler
    Elisa Luzón
    Alberto Levy Naon
    Respiratory Research, 24
  • [47] Achieving clinical outcomes with benralizumab in severe eosinophilic asthma patients in a real-world setting: orbe II study
    Padilla-Galo, Alicia
    Carmona, Isabel Moya
    Ausin, Pilar
    Fernandez, Luis Carazo
    Garcia-Moguel, Ismael
    Velasco-Garrido, Jose Luis
    Andujar-Espinosa, Ruben
    Casas-Maldonado, Francisco
    Martinez-Moragon, Eva
    Rivera, Carlos Martinez
    Solsona, Elisabet Vera
    Lopez, Fernando Sanchez-Toril
    Alonso, Andrea Trisan
    Aparicio, Marina Blanco
    Valverde-Monge, Marcela
    Azcona, Borja Valencia
    Cervera, Marta Palop
    Nuevo, Javier
    Tena, Jesus Sanchez
    Resler, Gustavo
    Luzon, Elisa
    Naon, Alberto Levy
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [48] Baseline Characteristics of Patients With Severe Asthma Treated With Mepolizumab: An Interim Analysis of a Multi-country Real-world Cohort
    Allehebi, R. O.
    Maturu, V. Nagarjuna
    Mahboub, B.
    Bavbek, S.
    Fernandez, P.
    Rosales, D. Cano
    Soares, C.
    Abreu, G.
    Valladares, R.
    Queiroz, J.
    Menezes, P.
    Raimondi, A.
    Aziz, F.
    Pizzichini, E.
    Laucho-Contreras, M.
    Noibi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [49] Real-world Evidence of Improved Patient Outcomes With Reslizumab in Non-exacerbating Patients With Severe Eosinophilic Asthma (SEA): A Subgroup Analysis
    Peters, Stephen
    Wechsler, Michael
    Chipps, Bradley
    Hill, Tanisha
    Ariely, Rinat
    Depietro, Michael
    Terasawa, Emi
    Thomason, Darren
    Panettieri, Reynold
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB27 - AB27
  • [50] Impact of Atopic Status, Prior Omalizumab Use and Baseline Blood Eosinophil Count Alone and in Combination With Total Serum IgE on Maintenance OCS Reduction Outcomes in Patients With Severe Asthma Treated With Mepolizumab in the REALITI-A Study
    Liu, M. C.
    Chaudhuri, R.
    Chupp, G. L.
    Heaney, L. G.
    Lee, J. K.
    Pilette, C.
    Brusselle, G.
    Cristancho, R. Alfonso
    Zhang, L.
    Howarth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
12345